HN2002000050A - Compuestos farmaceuticamente activos - Google Patents
Compuestos farmaceuticamente activosInfo
- Publication number
- HN2002000050A HN2002000050A HN2002000050A HN2002000050A HN2002000050A HN 2002000050 A HN2002000050 A HN 2002000050A HN 2002000050 A HN2002000050 A HN 2002000050A HN 2002000050 A HN2002000050 A HN 2002000050A HN 2002000050 A HN2002000050 A HN 2002000050A
- Authority
- HN
- Honduras
- Prior art keywords
- active compounds
- pharmaceutically active
- etil
- useful
- phosphodyphate
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 abstract 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical class C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 abstract 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 abstract 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 abstract 1
- 101100189582 Dictyostelium discoideum pdeD gene Proteins 0.000 abstract 1
- 101150098694 PDE5A gene Proteins 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 102100029175 cGMP-specific 3',5'-cyclic phosphodiesterase Human genes 0.000 abstract 1
- 229940029575 guanosine Drugs 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS FARMACEUTICAMENTE UTILES Y EN PARTICULAR, A 5 (2-BUTOXI - 3 - (1 - HIDROXIETIL) - 3 - PIRIDINIL - 3 - ETIL - 2 - (1 - ETIL - - AZETIDINIL) - 2, 6 - DIHIDRO - 7H - PIRAZOLO (4, 3 - D) PIRIMIDIN 7 - ONA, QUE SSON UTILES EN LA INHIBICION DE LAS FOSFODIESTERASAS DE GUANOSINA 3', 5' - MONOFOSFATO CICLICO DE TIPO 5 (GMPc PDE5).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0105893.2A GB0105893D0 (en) | 2001-03-09 | 2001-03-09 | Pharmaceutically active compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HN2002000050A true HN2002000050A (es) | 2002-09-13 |
Family
ID=9910362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HN2002000050A HN2002000050A (es) | 2001-03-09 | 2002-03-08 | Compuestos farmaceuticamente activos |
Country Status (8)
| Country | Link |
|---|---|
| AP (1) | AP2002002462A0 (es) |
| GB (1) | GB0105893D0 (es) |
| GT (1) | GT200200044A (es) |
| HN (1) | HN2002000050A (es) |
| PA (1) | PA8541101A1 (es) |
| PE (1) | PE20021153A1 (es) |
| TN (1) | TNSN02023A1 (es) |
| WO (1) | WO2002072586A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
| US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
| PT1572173E (pt) | 2002-12-13 | 2010-05-10 | Warner Lambert Co | Ligando alfa-2-delta para tratar sintomas do tracto urinário inferior |
| MXPA06000623A (es) * | 2003-07-16 | 2006-04-11 | Pfizer | Tratamiento de la disfuncion sexual. |
| WO2007014929A1 (en) | 2005-08-03 | 2007-02-08 | Boehringer Ingelheim International Gmbh | Use of flibanserin in the treatment of obesity |
| JP2009513604A (ja) | 2005-10-29 | 2009-04-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体 |
| WO2008000760A1 (en) | 2006-06-30 | 2008-01-03 | Boehringer Ingelheim International Gmbh | Flibanserin for the treatment of urinary incontinence and related diseases |
| BRPI0716439B8 (pt) | 2006-08-14 | 2021-05-25 | Boehringer Ingelheim Int | sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos |
| BRPI0716436B8 (pt) | 2006-08-25 | 2021-05-25 | Boehringer Ingelheim Int | sistema de liberação controlada e método para fabricação do mesmo |
| PE20091188A1 (es) | 2007-09-12 | 2009-08-31 | Boehringer Ingelheim Int | Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen |
| CA2686480A1 (en) | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | New salts |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1073658E (pt) * | 1998-04-20 | 2003-12-31 | Pfizer | Inibidores de ogmp pdes de pirazolopirimidinona para o tratamento da disfuncao sexual |
| GB9823101D0 (en) * | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
| EA200200240A1 (ru) * | 1999-10-11 | 2002-10-31 | Пфайзер Инк. | 5-(2-ЗАМЕЩЕННЫЕ-5-ГЕТЕРОЦИКЛИЛСУЛЬФОНИЛПИРИД-3-ИЛ)-ДИГИДРОПИРАЗОЛО[4,3-d]ПИРИМИДИН-7-ОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ФОСФОДИЭСТЕРАЗЫ |
| CO5271697A1 (es) * | 2000-01-12 | 2003-04-30 | Pfizer Prod Inc | Composiciones y procedimientos para el tratamiento de afecciones que responden a un aumento de testosterona |
-
2001
- 2001-03-09 GB GBGB0105893.2A patent/GB0105893D0/en not_active Ceased
-
2002
- 2002-02-27 WO PCT/IB2002/000622 patent/WO2002072586A1/en not_active Ceased
- 2002-03-06 GT GT200200044A patent/GT200200044A/es unknown
- 2002-03-07 AP APAP/P/2002/002462A patent/AP2002002462A0/en unknown
- 2002-03-07 PE PE2002000183A patent/PE20021153A1/es not_active Application Discontinuation
- 2002-03-08 PA PA20028541101A patent/PA8541101A1/es unknown
- 2002-03-08 HN HN2002000050A patent/HN2002000050A/es unknown
- 2002-03-08 TN TNTNSN02023A patent/TNSN02023A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20021153A1 (es) | 2002-12-17 |
| GT200200044A (es) | 2002-12-02 |
| WO2002072586A1 (en) | 2002-09-19 |
| TNSN02023A1 (fr) | 2005-12-23 |
| PA8541101A1 (es) | 2003-11-12 |
| AP2002002462A0 (en) | 2002-06-30 |
| GB0105893D0 (en) | 2001-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2022024I1 (el) | Πυριμιδινες που αναστελλουν τον πολλαπλασιασμο toy hiv | |
| HN2004000538A (es) | "PIRIDO[ 2,3-d ] PIRIMIDINA-2,4-DIAMINAS COMO-INHIBIDORES DE PDE 2" | |
| DK1265889T3 (da) | Lægemidler imod virussygdomme | |
| DE60215157D1 (de) | Verwendungen von antiviralen nucleosid-derivaten zur herstellung eines medikaments zur behandlung von hepatitis c infektionen | |
| EP1371406A4 (en) | HONEYCOMB STRUCTURE BODY | |
| BG108268A (en) | Pyrazolopyrimidines as therapeutic agents | |
| ITRM20000483A0 (it) | Capo di abbigliamento strutturato per la protezione del motociclista. | |
| HN2001000224A (es) | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos. | |
| EP1401840A4 (en) | NEW 4-AMINO-5,6-SUBSTITUTED THIOPHENO 2,3 D | PYRIMIDINE | |
| BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
| ATE388713T1 (de) | 4-amino-6-phenyl-pyrrolo(2,3-d)pyrimidin derivate | |
| EP1495141A4 (en) | THERAPY OF HIV | |
| MXPA03000803A (es) | Suministro vaginal de bisfosfonatos. | |
| BR9902086A (pt) | Formulações farmacêuticas. | |
| BR0108485A (pt) | Derivados do antiviral azaindol | |
| HN2001000027A (es) | Derivados de purina | |
| HUP0401190A3 (en) | Treatment of nail infections using no generating compositions | |
| CY1105390T1 (el) | Θepαπευτικη αγωγη της πνευμονικης υπερτασης | |
| BR0208154A (pt) | Inibidores de fosfodiesterase 3',5'-mono-fosfato guanosina cìclica | |
| PT1513514E (pt) | Formulações tópicas de hidroximatairesinol | |
| HN2002000050A (es) | Compuestos farmaceuticamente activos | |
| ITTO20010120A0 (it) | Procedimento per la fabbricazione di un corpo cavo costituente un componente di bicicletta, in particolare per la fabbricazione della scatol | |
| BRPI0313080A2 (pt) | formulações com geração de aerossol reduzida | |
| ITPD20040244A1 (it) | Tavola di mobilizzazione passiva dell'articolazione della caviglia. | |
| EP1565583A4 (en) | HIV VACCINE FORMULATIONS |